- Home
- ATTO vs CEVA Comparison
ATTO vs CEVA Comparison
Compare ATTO & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATTO | CEVA |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 852.2M |
| IPO Year | 2026 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ATTO | CEVA |
|---|---|---|
| Price | $17.70 | $34.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $30.33 |
| AVG Volume (30 Days) | 264.4K | ★ 556.1K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $87,507,000.00 |
| Revenue This Year | N/A | $12.37 |
| Revenue Next Year | N/A | $13.82 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.45 |
| 52 Week Low | $16.15 | $17.02 |
| 52 Week High | $28.00 | $51.60 |
Technical Indicators
Market Signals| Indicator | ATTO | CEVA |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 65.11 |
| Support Level | $16.15 | $26.17 |
| Resistance Level | $24.89 | $39.71 |
| Average True Range (ATR) | 2.07 | 1.41 |
| MACD | -0.70 | 0.99 |
| Stochastic Oscillator | 9.50 | 90.41 |
Price Performance
Historical ComparisonAbout ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived mainly from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems. The company operates in one reportable segment: the licensing of IP to semiconductor companies and electronic equipment manufacturers.